Physician profile

Kathleen Ann Smith

Family Medicine · Columbus, IN

NPI 1841392883

$1,709.21

in general payments reported to CMS, 2019-2025

36 companies · $214 in 2025

The $214 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

See the full distribution for Family Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,192.91

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $263.20 2019-2025 Ozempic, Rybelsus, Wegovy
Ironshore Pharmaceuticals INC. $192.25 2024
Pfizer INC. $178.63 2019-2025
Lilly USA, LLC $116.39 2019-2025 Mounjaro, Zepbound, Jardiance
Abbvie INC. $79.10 2019-2024
Medtronic, INC. $69.96 2023-2024 Minimed 780g, Intellis Adaptivestim
Glaxosmithkline, LLC. $63.54 2021-2025 Shingrix, Trelegy Ellipta, Arexvy
Exact Sciences Corporation $56.54 2023-2024 Cologuard Collection Kit
Vanda Pharmaceuticals INC. $53.22 2022-2025 Fanapt
Kvk-Tech, INC. $50.89 2024
Smith+Nephew, INC. $48.78 2019-2023 Collagenase Santyl
Astrazeneca Pharmaceuticals LP $43.37 2022-2025
Sanofi Pasteur INC. $39.47 2019-2023
Amarin Pharma, INC. $36.02 2019
Tandem Diabetes Care, INC. $33.20 2023-2024 T:Slim X2 Insulin Pump With Control-Iq
Show all 36 companies
CompanyGeneral paymentsYearsTop products
Lundbeck LLC $32.52 2022-2023 Rexulti
Aroa Biosurgery Incorporated $32.09 2019
Integra Lifesciences Corporation $28.51 2020-2023 Tcc-Ez
Astellas Pharma US INC $26.30 2019-2020
Xeris Pharmaceuticals, INC. $24.31 2024 Gvoke Hypopen
Boehringer Ingelheim Pharmaceuticals, INC. $22.77 2025 Jardiance
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $20.48 2023 Xifaxan
Collegium Pharmaceutical, INC. $20.09 2025 Jornay Pm
Shield Therapeutics INC $17.66 2024
Almatica Pharma LLC $16.72 2023 Loreev Xr
Daiichi Sankyo INC. $16.52 2019
Abbott Laboratories $16.05 2021
Paratek Pharmaceuticals, INC. $15.45 2025 Nuzyra
Novartis Pharmaceuticals Corporation $14.91 2019
Antares Pharma, INC. $14.32 2023 Xyosted, Tlando, Nocdurna
Takeda Pharmaceuticals U.S.A., INC. $14.01 2023 Trintellix
Amgen INC. $13.93 2019
Mayne Pharma Commercial LLC $12.24 2020
Otsuka America Pharmaceutical, INC. $12.10 2022
Sanofi-Aventis U.S. LLC $12.01 2019
Phathom Pharmaceuticals, INC. $1.66 2025 Voquezna

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kathleen Ann Smith

$1,709.21

in general payments reported 2019-2025

Years
2019-2025
Top company
Novo Nordisk INC
Context
The $214 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/473161/kathleen-ann-smith

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.